Exact Mass: 792.375443
Exact Mass Matches: 792.375443
Found 78 metabolites which its exact mass value is equals to given mass value 792.375443
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Betavulgaroside II
Betavulgaroside II is found in root vegetables. Betavulgaroside II is a constituent of Beta vulgaris (sugar beet). Constituent of Beta vulgaris (sugar beet). Betavulgaroside II is found in root vegetables.
Lyciumoside II
Constituent of Lycium chinense (Chinese boxthorn). Lyciumoside II is found in tea, coffee and coffee products, and herbs and spices. Lyciumoside II is found in coffee and coffee products. Lyciumoside II is a constituent of Lycium chinense (Chinese boxthorn).
(2S,3R,4R,5R,6S)-2-[(2R,3S,4R,5R,6R)-4,5-dihydroxy-2-(hydroxymethyl)-6-[[7-[2-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]-1,1,4a,7-tetramethyl-3,4,4b,5,6,8,10,10a-octahydro-2H-phenanthren-2-yl]oxy]oxan-3-yl]oxy-6-methyloxane-3,4,5-triol
3-O-beta-D-glucuropyranosyl-30-norolean-12,20(29)-dien-23-aldehyde-28-oic acid-28-O-beta-D-glucoside|3beta-hydroxy-23-oxo-30-noroleana-12,20(29)-diene-28-oic acid 3-O-beta-D-glucuronopyranosyl-28-O-beta-D-glucopyranoside|bigelovii B
beta-D-glucopyranosyl-(1->2)-[beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranosyl-(1->6)]-1-O-octanoyl-beta-D-glucopyranose|nonioside T
stauntogenin 3-O-alpha-oleandropyranosyl-(1?4)-beta-digitoxopyranosyl-(1?4)-beta-oleandropyranoside
methyl 2-diphenylphosphanyl-4-[3-[2-[2-[3-[5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl)pentanoylamino]propoxy]ethoxy]ethoxy]propylcarbamoyl]benzoate
Anhydrovinblastine
C46H56N4O8 (792.4097936000001)
Anhydrovinblastine has been used in trials studying the treatment of Unspecified Adult Solid Tumor, Protocol Specific. Anhydrovinblastine is a semisynthetic derivative of the vinca alkaloid vinblastine, with potential antineoplastic activity. Like vinblastine, anhydrovinblastine targets and binds to tubulin and inhibits microtubule formation, resulting in disruption of mitotic spindle assembly and causing tumor cell cycle arrest in the M phase. C274 - Antineoplastic Agent > C1931 - Antineoplastic Plant Product > C932 - Vinca Alkaloid Compound C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent D000970 - Antineoplastic Agents > D014748 - Vinca Alkaloids C1907 - Drug, Natural Product
C38H64O17_Hexopyranoside, 1-[7-[[4-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-1,2,3,4,4a,4b,5,6,7,8,8a,9-dodecahydro-2,4b,8,8-tetramethyl-2-phenanthrenyl]-2-hydroxyethyl
Phosphine-biotin
Lyciumoside II
A diterpene glycoside that is 20-hydroxygeranyllinalool substituted carrying beta-D-glucosyl and beta-D-glucosyl-(1->2)-beta-D-glucosyl residues at position O-3 and O-20 respectively.
Betavulgaroside II
(Tetra-t-butylphthalocyaninato)iron(II)
C48H48FeN8 (792.3351117999999)
Cenicriviroc mesylate
C42H56N4O7S2 (792.3590226000001)
D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents C308 - Immunotherapeutic Agent > C63817 - Chemokine Receptor Antagonist D065100 - CCR5 Receptor Antagonists
Anhydrovinblastine
C46H56N4O8 (792.4097936000001)
D000970 - Antineoplastic Agents > D014748 - Vinca Alkaloids
[(1R,3E,5R,7Z,9S,11S,13S,15R,17R,21R,23R,24S)-1,11,17-trihydroxy-21-[(1S)-1-hydroxyethyl]-7-(2-methoxy-2-oxoethylidene)-2,2,12,12-tetramethyl-19,26-dioxo-20,25,30,31,32-pentaoxapentacyclo[21.6.1.15,9.111,15.024,28]dotriaconta-3,27-dien-13-yl] 2,2-dimethylpropanoate
alpha-3,4-Anhydrovinblastine radical
C46H56N4O8+2 (792.4097936000001)
[(2S,3S,6S)-6-[3-[(8E,11E,14E)-heptadeca-8,11,14-trienoyl]oxy-2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid
[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-[hydroxy-[(5R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxypropyl] (7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoate
[1-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-[hydroxy-[(5R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxypropan-2-yl] (7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoate
Galnon (TFA)
Galnon TFA is a selective and non-peptide agonist of galanin GAL1 and GAL2 receptor, with Kis of 11.7 and 34.1 μM respectively. Galnon TFA exhibits anticonvulsant and anxiolytic effects[1][2].
(2s,3r,4s,5s,6r)-2-{[(2r,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-2-{[(2z,6e,10e,14s)-2,6,10,14-tetramethyl-14-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexadeca-2,6,10,15-tetraen-1-yl]oxy}oxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(1r,3s,3ar,4r,5r,6r,7as)-6-[(1s,2r,3r,4s,6s)-4-(acetyloxy)-6-hydroxy-2-(2-methoxy-2-oxoethyl)-1,3-dimethyl-7,9-dioxabicyclo[4.2.1]nonan-3-yl]-5-(formyloxy)-3-(furan-3-yl)-7a-hydroxy-3a-methyl-7-methylidene-1-[(2-methylpropanoyl)oxy]-hexahydroinden-4-yl (2r,3r)-2-hydroxy-3-methylpentanoate
4-{[3,5-bis(acetyloxy)-4-{[5-(acetyloxy)-3,4-dihydroxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-5-hydroxy-2-methyl-6-(octyloxy)oxan-3-yl hexanoate
(1s,4e,6r,8e,10s,12s,14s,16r,18r,22s,23r,25s,27r)-12,18,23-trihydroxy-8-(2-methoxy-2-oxoethylidene)-3,3,13,13,22-pentamethyl-2,20,29-trioxo-21,30,31,32,33-pentaoxapentacyclo[23.5.1.1⁶,¹⁰.1¹²,¹⁶.0¹,²⁷]tritriacont-4-en-14-yl 2,2-dimethylpropanoate
(2s,3s,4s,5r,6r)-4-{[(2s,3r,4r,5s,6s)-3,5-bis(acetyloxy)-4-{[(2s,3r,4r,5r,6s)-3-(acetyloxy)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-5-hydroxy-2-methyl-6-(octyloxy)oxan-3-yl hexanoate
methyl (2r,5r,6s,8s,9s,10r)-14-[(1r,9s,12r,13z,18r)-13-ethylidene-4-methoxy-18-(methoxycarbonyl)-6-methyl-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0⁹,¹⁵]octadeca-2,4,6-trien-5-yl]-15-methoxy-6,18-dimethyl-3-(2-methylpropanoyl)-7-oxa-3,18-diazapentacyclo[9.7.0.0²,⁸.0⁵,⁹.0¹²,¹⁷]octadeca-1(11),12,14,16-tetraene-10-carboxylate
C46H56N4O8 (792.4097936000001)